Latest Allergen immunotherapy Stories
DUBLIN, Feb .19, 2015 /PRNewswire/ --Research and Markets
STALLERGENES exercised option to pursue the exclusive development of application of ActoGeniX's technology for targeted delivery of allergen-based treatments ANTONY, France and GHENT,
New Personalized Toothpaste Addresses Underlying Cause of Seasonal and Year-Round Allergies MADISON, Wis., Oct.
MISSISSAUGA, ON, Oct. 22, 2014 /PRNewswire/ - Nuvo Research Inc.
ITI has submitted a new IND for a Phase II clinical study of the JRC Vaccine Hershey, PA & Rockville, MD (PRWEB) October 01, 2014 DNA Vaccine pioneer
MarketOptimizer.org adds “OpportunityAnalyzer Allergic Rhinitis – Allergen-Specific Immunotherapy – Opportunity Analysis and Forecast to 2018” to its store.
Ragweed is the most common cause of fall hay fever and affects people in virtually every part of the country.
ITI moves one step closer to a solution for the worldwide allergy crisis. Hershey, PA & Rockville, MD (PRWEB) August 21, 2014 DNA vaccine pioneer
Mesa, Arizona-based allergist, Dr.
Wisconsin allergists share pioneering expertise through Allergychoices' August medical conference. Onalaska, Wis.
- A political dynamiter.